Incyte Corporation (INCY) is an American biopharmaceutical company specializing in the research, development, and commercialization of therapies focused on oncology and other serious diseases. The company is known for its strong emphasis on scientific research and innovation, leading to the discovery of new therapeutic possibilities. Incyte focuses on developing small molecule drugs and immunotherapies that have the potential to significantly improve patients' lives. Incyte Corporation (INCY) shares might be appealing to investors seeking involvement in the biotechnology sector with a focus on innovation and treatment of serious diseases.